期刊文献+

多巴丝肼片联合普拉克索治疗帕金森病患者的临床效果分析 被引量:47

下载PDF
导出
摘要 帕金森病(PD)在临床中是一种常见的神经系统变性疾病,患者多为中老年群体,90%患者为原发性PD,该病患病率存在种族差异,白种人患病率远高于黄种人和黑种人,我国患者多集中于55岁以上的民众,严重影响其生存质量[1]。病发后,患者可会出现静止性震颤、肌强直、运动迟缓等临床表现,而部分患者可出现非运动症状,易降低其生活品质,加重社会负担[2]。药物治疗因疗效确切、见效快、使用方便,较受医患推崇.
出处 《山西医药杂志》 CAS 2019年第6期685-687,共3页 Shanxi Medical Journal
  • 相关文献

参考文献7

二级参考文献49

  • 1吕荣祥.美多巴联合普拉克索治疗帕金森病的有效性及安全性研究[J].中国生化药物杂志,2014,34(3):153-155. 被引量:46
  • 2Litvan I,Goldman JG,Trster AI,et al.Diagnostic criteria for mild cognitive impairment in Parkinson's disease:Movement Disorder Society Task Force guidelines[J].Movement Disorders,2012;27(3):349-56. 被引量:1
  • 3Lill CM,Roehr JT,Mc Queen MB,et al.Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics:The PDGene database[J].PLo S Genetics,2012;8(3):e1002548. 被引量:1
  • 4Muller T,Hellwig R,Muhlack S.Levodopa induces synthesis of nerve growth factor and growth hormone in patients with Parkinson disease[J].Clin Neuropharmacol,2011;34(3):101-3. 被引量:1
  • 5Schapira AH,Mc Dermott MP,Barone P,et al.Pramipexole in patients with early Parkinson's disease(PROUD):a randomised delayed-start trial[J].Lancet Neurol,2013;12(8):747-55. 被引量:1
  • 6Broen MP,Moonen AJ,Kuijf ML,et al.Factor analysis of the Hamilton Depression Rating Scale in Parkinson's disease[J].Parkinsonism Relat Dis,2015;21(2):142-6. 被引量:1
  • 7Kataoka H,Tanaka N,Saeki K,et al.Low frontal assessment battery score as a risk factor for falling in patients with Hoehn-Yahr StageⅢParkinson's disease:a 2-year prospective study[J].European Neurol,2013;71(3-4):187-92. 被引量:1
  • 8Hauser RA,Schapira AH,Barone P,et al.Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease[J].European J Neurol,2014;21(5):736-43. 被引量:1
  • 9Mizuno Y,Yamamoto M,Kuno S,et al.Efficacy and Safety of ExtendedVersus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-dopa-Undertreated Parkinson Disease:A Double-Blind,Randomized Trial[J].Clin Neuropharmacol,2012;35(4):174-81. 被引量:1
  • 10Eggert K,hlwein C,Kassubek J,et al.Influence of the nonergot dopamine agonist piribedil on vigilance in patients with parkinson disease and excessive daytime sleepiness(Pi Vi Cog-PD):an 11-week randomized comparison trial against pramipexole and ropinirole[J].Clin Neuropharmacol,2014;37(4):116-22. 被引量:1

共引文献127

同被引文献306

引证文献47

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部